White label ELPA - ClinicalTrials.eu

Study of venetoclax with fludarabine, cytarabine and idarubicin combination therapy in newly diagnosed patients with intermediate or high-risk Acute Myeloid Leukemia

Not recruiting

1 1 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
Study on Headache Effects of Sildenafil and Placebo in Men and Women with Episodic Migraine Without Aura

Not recruiting

1 1 1
Investigated diseases:
- Migraine without aura
Investigated drugs:
Study on the Safety and Effects of OMS906 for Patients with C3 Glomerulopathy and Idiopathic Immune Complex-Mediated Glomerulonephritis

Not recruiting

2 1 1
Investigated diseases:
- Glomerulonephritis
Investigated drugs:
- Oms906
Comparison of Atropine 0.

Not recruiting

3 1 1 1
Investigated diseases:
- Myopia
Investigated drugs:
- Atropine Sulfate
Study of Osimertinib and Savolitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Osimertinib Treatment

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
- Non-small cell lung cancer metastatic
Investigated drugs:
- Osimertinib
- Savolitinib
Study on the Safety and Effects of LY3884963 for Patients with Fronto-Temporal Dementia with Progranulin Mutations

Not recruiting

1 1 1 1
Investigated diseases:
- Frontotemporal dementia
Investigated drugs:
Study of RMC-035 to prevent kidney injury in patients undergoing open-chest heart surgery

Not recruiting

2 1
Investigated diseases:
- Renal failure
Investigated drugs:
- Rmc-035
Study on the Safety and Effectiveness of Azacitidine and Pembrolizumab for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Platinum Treatment

Not recruiting

2 1 1
Investigated drugs:
- Azacitidine
- Pembrolizumab
Study on Ibrutinib and Venetoclax for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

Not recruiting

2 1 1 1
Investigated diseases:
- Chronic lymphocytic leukaemia refractory
- Chronic lymphocytic leukaemia
Investigated drugs:
- Venetoclax
Study of IDRX-42 for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)

Not recruiting

1 1 1
Investigated drugs:
- [4-(Methyl-1H-Pyrazol-4-Yl)-Benzyl] (6[7-(3-Pyrrolidin-1-Yl-Propoxy)-Imidazo[1,2-A] Pyridin-3-Yl]-Pyrimidin-4-Yl]-Amine

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies